When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
ADMS - Adamas Pharma settles patent dispute with Osmotica for $7.5M
Adamas Pharmaceuticals Inc.
Adamas Pharmaceuticals (ADMS) inks an agreement with Osmotica Pharmaceutical US LLC settling the patent litigation related to Osmolex ER (amantadine).The company will acquire global rights to Osmolex ER for $7.5M.The deal should close next quarter.